These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework. Bain E; Bubner T; Ashwood P; Van Ryswyk E; Simmonds L; Reid S; Middleton P; Crowther CA BMC Pregnancy Childbirth; 2015 Aug; 15():176. PubMed ID: 26283623 [TBL] [Abstract][Full Text] [Related]
25. Proximity of magnesium exposure to delivery and neonatal outcomes. Turitz AL; Too GT; Gyamfi-Bannerman C Am J Obstet Gynecol; 2016 Oct; 215(4):508.e1-6. PubMed ID: 27177525 [TBL] [Abstract][Full Text] [Related]
26. Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand - Ongoing barriers and enablers. Gatman K; May R; Crowther C Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):44-48. PubMed ID: 31119725 [TBL] [Abstract][Full Text] [Related]
27. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Costantine MM; Weiner SJ; Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997 [TBL] [Abstract][Full Text] [Related]
28. Antenatal magnesium sulfate for neuroprotection before preterm birth? Stanley FJ; Crowther C N Engl J Med; 2008 Aug; 359(9):962-4. PubMed ID: 18753653 [No Abstract] [Full Text] [Related]
29. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate. Cuff RD; Sullivan SA; Chang EY J Matern Fetal Neonatal Med; 2020 Mar; 33(6):982-986. PubMed ID: 30122071 [No Abstract] [Full Text] [Related]
30. Effects and Safety of Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines. Zeng X; Xue Y; Tian Q; Sun R; An R Medicine (Baltimore); 2016 Jan; 95(1):e2451. PubMed ID: 26735551 [TBL] [Abstract][Full Text] [Related]
31. A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth. Hellström S; Jonsdotter A; Jonsson M; Pettersson K; Saltvedt S; Herbst A; Ågren J; Ådén U; Domellöf M; Hagberg H; Carlsson Y Acta Obstet Gynecol Scand; 2023 Dec; 102(12):1741-1748. PubMed ID: 37680134 [TBL] [Abstract][Full Text] [Related]
32. In defense of magnesium sulfate. Elliott JP; Lewis DF; Morrison JC; Garite TJ Obstet Gynecol; 2009 Jun; 113(6):1341-1348. PubMed ID: 19461432 [TBL] [Abstract][Full Text] [Related]
33. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial. Wolf HT; Brok J; Henriksen TB; Greisen G; Salvig JD; Pryds O; Hedegaard M; Weber T; Hegaard HK; Pinborg A; Huusom LD; BJOG; 2020 Sep; 127(10):1217-1225. PubMed ID: 32237024 [TBL] [Abstract][Full Text] [Related]
34. Neonatal effects of magnesium sulfate given to the mother. Abbassi-Ghanavati M; Alexander JM; McIntire DD; Savani RC; Leveno KJ Am J Perinatol; 2012 Nov; 29(10):795-9. PubMed ID: 22773290 [TBL] [Abstract][Full Text] [Related]
35. Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. The Neonatal Brain Hemorrhage Study Analysis Group. Paneth N; Jetton J; Pinto-Martin J; Susser M Pediatrics; 1997 May; 99(5):E1. PubMed ID: 9113958 [TBL] [Abstract][Full Text] [Related]
36. [Evidence exists for prophylactic magnesium sulphate as a neuroprotector in premature births]. Wolf HT; Hegaard HK; Huusom L; Greisen G; Hedegaard M Ugeskr Laeger; 2011 Mar; 173(13):962-5. PubMed ID: 21453636 [TBL] [Abstract][Full Text] [Related]